98 related articles for article (PubMed ID: 12676408)
41. A case study of the effectiveness of nurse-led screening programmes for cervical cancer among Hong Kong Chinese women.
Twinn S; Cheng F
J Adv Nurs; 1999 May; 29(5):1089-96. PubMed ID: 10320491
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness of campaigns to increase Pap smear screening.
Shelley J; Irwig L; Simpson JM; Laverty C
Med J Aust; 1993 Mar; 158(5):359. PubMed ID: 8474386
[No Abstract] [Full Text] [Related]
43. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
44. Limited Understanding of Pap Smear Testing among Women, a Barrier to Cervical Cancer Screening in the United Arab Emirates.
AL-Hammadi FA; Al-Tahri F; Al-Ali A; Nair SC; Abdulrahman M
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3379-3387. PubMed ID: 29286607
[TBL] [Abstract][Full Text] [Related]
45. Cervical cancer screening: How our approach may change.
Hofmeister S
J Fam Pract; 2016 Aug; 65(8):551-3. PubMed ID: 27660838
[TBL] [Abstract][Full Text] [Related]
46. Results of a cluster randomized trial testing the Systems Analysis and Improvement Approach to increase cervical cancer screening in family planning clinics in Mombasa County, Kenya.
Eastment MC; Wanje G; Richardson BA; Mwaringa E; Patta S; Sherr K; Barnabas RV; Mandaliya K; Jaoko W; Mcclelland RS
Implement Sci; 2023 Nov; 18(1):66. PubMed ID: 38012647
[TBL] [Abstract][Full Text] [Related]
47. Women getting regular care may prefer Pap tests for cancer screening.
Perspect Sex Reprod Health; 2015 Jun; 47(2):110. PubMed ID: 26095737
[No Abstract] [Full Text] [Related]
48. Cervical cancer risk levels in Turkey and compliance to the national cervical cancer screening standard.
Açikgöz A; Ergör G
Asian Pac J Cancer Prev; 2011; 12(4):923-7. PubMed ID: 21790227
[TBL] [Abstract][Full Text] [Related]
49. [Cytodiagnosis of cervical cancer: efficacy of the passive preventive care].
Ejmocka-Ambroziak A; Wiczyńska-Zajac A; Kilijańczyk M
Ginekol Pol; 2000 Sep; 71(9):1157-63. PubMed ID: 11082995
[TBL] [Abstract][Full Text] [Related]
50. Cervical cancer in Kenya: prospects for early detection at primary level.
Mati JK; Mbugua S; Wanderi P
Int J Gynaecol Obstet; 1994 Dec; 47(3):261-7. PubMed ID: 7705532
[TBL] [Abstract][Full Text] [Related]
51. Cervical cancer screening after 50: near extinction?
Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
[TBL] [Abstract][Full Text] [Related]
52. Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.
Martinez-Huedo MA; Lopez de Andres A; Hernandez-Barrera V; Carrasco-Garrido P; Martinez Hernandez D; Jiménez-Garcia R
Diabetes Metab; 2012 Apr; 38(2):142-8. PubMed ID: 22078638
[TBL] [Abstract][Full Text] [Related]
53. Predictors of Pap smear screening in socioeconomically disadvantaged elderly women.
Weinrich S; Coker AL; Weinrich M; Eleazer GP; Greene FL
J Am Geriatr Soc; 1995 Mar; 43(3):267-70. PubMed ID: 7884116
[TBL] [Abstract][Full Text] [Related]
54. Integration of routine rapid HIV screening in an urban family planning clinic.
Criniti SM; Aaron E; Hilley A; Wolf S
J Midwifery Womens Health; 2011; 56(4):395-399. PubMed ID: 21733112
[TBL] [Abstract][Full Text] [Related]
55. Who has Pap tests? Variables associated with the use of Pap tests in absence of screening programmes.
Ronco G; Segnan N; Ponti A
Int J Epidemiol; 1991 Jun; 20(2):349-53. PubMed ID: 1917233
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
57. Cervix cancer screening among Greek and immigrant women: the experience of a Greek District Hospital.
Paraskevopoulou E; Economou A; Panagopoulos P; Zikopoulos M; Petrakos G; Koutras I
Clin Exp Obstet Gynecol; 2005; 32(1):52-4. PubMed ID: 15864939
[TBL] [Abstract][Full Text] [Related]
58. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
[TBL] [Abstract][Full Text] [Related]
59. Factors relating to cervical screening in New South Wales, Australia.
Perkins JJ; Sanson-Fisher RW; Byles JE; Tiller K
Health Place; 1999 Sep; 5(3):223-33. PubMed ID: 10984577
[TBL] [Abstract][Full Text] [Related]
60. An evaluation of a campaign to increase cervical cancer screening in rural Victoria.
Hirst S; Mitchell H; Medley G
Community Health Stud; 1990; 14(3):263-8. PubMed ID: 2253461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
